Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine and methotrexate in recurrent or metastatic SCCHN
NCT02347332Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2014
- Primary completion
- Oct 2017
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinflunine in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Pierre Fabre Laboratories. Started Apr 2014; status: completed.
02
Drugs
vinflunine
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02347332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347332.